Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
25+ Key Opinion Leaders (KOLs) were contacted for insights on Glucagon-like Peptide-1 (GLP-1) Agonists incorporation in the evolving treatment landscape, patient reliance on conventional therapies, patient therapy switching acceptability, drug uptake, along with challenges related to accessibility
Apart from stimulating the secretion of either insulin or glucagon in glucose-dependent manner [33], GIP promotes lipogenesis and lipid deposition under conditions of hyperinsulinema [34,35,36] while stimulating lipolysis and fatty acid oxidation under conditions of normo- or hypoinsulinemia [37,38,39]
H.RemmeN.HabelA.ChankhamjonP.ScherlachK.HeinekampT.et al (2011)
Theyre often aware of health trends, and tend to eat healthier as a whole
US$ 23.91
US$ 26.61
US$ 25.95
US$ 27.52
US$ 19.99
